Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles

L. Vannucci, E. Falvo, M. Fornara, P. Di Micco, O. Benada, J. Krizan, J. Svoboda, K. Hulikova-Capkova, V. Morea, A. Boffi, P. Ceci

. 2012 ; 7 () : 1489-1509.

Language English Country New Zealand

Document type Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND: Nanoparticle-based systems are promising for the development of imaging and therapeutic agents. The main advantage of nanoparticles over traditional systems lies in the possibility of loading multiple functionalities onto a single molecule, which are useful for therapeutic and/or diagnostic purposes. These functionalities include targeting moieties which are able to recognize receptors overexpressed by specific cells and tissues. However, targeted delivery of nanoparticles requires an accurate system design. We present here a rationally designed, genetically engineered, and chemically modified protein-based nanoplatform for cell/tissue-specific targeting. METHODS: Our nanoparticle constructs were based on the heavy chain of the human protein ferritin (HFt), a highly symmetrical assembly of 24 subunits enclosing a hollow cavity. HFt-based nanoparticles were produced using both genetic engineering and chemical functionalization methods to impart several functionalities, ie, the α-melanocyte-stimulating hormone peptide as a melanoma-targeting moiety, stabilizing and HFt-masking polyethylene glycol molecules, rhodamine fluorophores, and magnetic resonance imaging agents. The constructs produced were extensively characterized by a number of physicochemical techniques, and assayed for selective melanoma-targeting in vitro and in vivo. RESULTS: Our HFt-based nanoparticle constructs functionalized with the α-melanocyte-stimulating hormone peptide moiety and polyethylene glycol molecules were specifically taken up by melanoma cells but not by other cancer cell types in vitro. Moreover, experiments in melanoma-bearing mice indicate that these constructs have an excellent tumor-targeting profile and a long circulation time in vivo. CONCLUSION: By masking human HFt with polyethylene glycol and targeting it with an α-melanocyte-stimulating hormone peptide, we developed an HFt-based melanoma-targeting nanoplatform for application in melanoma diagnosis and treatment. These results could be of general interest, because the same strategy can be exploited to develop ad hoc nanoplatforms for specific delivery towards any cell/tissue type for which a suitable targeting moiety is available.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12034481
003      
CZ-PrNML
005      
20200505133257.0
007      
ta
008      
121023s2012 nz f 000 0|eng||
009      
AR
024    7_
$a 10.2147/ijn.s28242 $2 doi
035    __
$a (PubMed)22619508
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a nz
100    1_
$a Vannucci, Luca. $7 xx0232557 $u Institute of Microbiology, Academy of Sciences of the Czech Republic, VVI, Prague, Czech Republic
245    10
$a Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles / $c L. Vannucci, E. Falvo, M. Fornara, P. Di Micco, O. Benada, J. Krizan, J. Svoboda, K. Hulikova-Capkova, V. Morea, A. Boffi, P. Ceci
520    9_
$a BACKGROUND: Nanoparticle-based systems are promising for the development of imaging and therapeutic agents. The main advantage of nanoparticles over traditional systems lies in the possibility of loading multiple functionalities onto a single molecule, which are useful for therapeutic and/or diagnostic purposes. These functionalities include targeting moieties which are able to recognize receptors overexpressed by specific cells and tissues. However, targeted delivery of nanoparticles requires an accurate system design. We present here a rationally designed, genetically engineered, and chemically modified protein-based nanoplatform for cell/tissue-specific targeting. METHODS: Our nanoparticle constructs were based on the heavy chain of the human protein ferritin (HFt), a highly symmetrical assembly of 24 subunits enclosing a hollow cavity. HFt-based nanoparticles were produced using both genetic engineering and chemical functionalization methods to impart several functionalities, ie, the α-melanocyte-stimulating hormone peptide as a melanoma-targeting moiety, stabilizing and HFt-masking polyethylene glycol molecules, rhodamine fluorophores, and magnetic resonance imaging agents. The constructs produced were extensively characterized by a number of physicochemical techniques, and assayed for selective melanoma-targeting in vitro and in vivo. RESULTS: Our HFt-based nanoparticle constructs functionalized with the α-melanocyte-stimulating hormone peptide moiety and polyethylene glycol molecules were specifically taken up by melanoma cells but not by other cancer cell types in vitro. Moreover, experiments in melanoma-bearing mice indicate that these constructs have an excellent tumor-targeting profile and a long circulation time in vivo. CONCLUSION: By masking human HFt with polyethylene glycol and targeting it with an α-melanocyte-stimulating hormone peptide, we developed an HFt-based melanoma-targeting nanoplatform for application in melanoma diagnosis and treatment. These results could be of general interest, because the same strategy can be exploited to develop ad hoc nanoplatforms for specific delivery towards any cell/tissue type for which a suitable targeting moiety is available.
650    _2
$a zvířata $7 D000818
650    _2
$a apoferritiny $x chemie $7 D001052
650    _2
$a lékové transportní systémy $7 D016503
650    _2
$a fluorescenční barviva $x chemie $x diagnostické užití $7 D005456
650    _2
$a buňky HT-29 $7 D019073
650    _2
$a lidé $7 D006801
650    _2
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a magnetické nanočástice $x chemie $x diagnostické užití $x ultrastruktura $7 D058185
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a melanom experimentální $x diagnóza $7 D008546
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a konfokální mikroskopie $7 D018613
650    _2
$a transmisní elektronová mikroskopie $7 D046529
650    _2
$a nanomedicína $7 D050997
650    _2
$a nanotechnologie $7 D036103
650    _2
$a polyethylenglykoly $x chemie $7 D011092
650    _2
$a stabilita proteinů $7 D055550
650    _2
$a rekombinantní proteiny $x chemie $7 D011994
650    _2
$a alfa-MSH $x chemie $x diagnostické užití $7 D000521
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Falvo, Elisabetta $u Regina Elena Cancer Institute, Pharmacokinetic/Pharmacogenomic Unit
700    1_
$a Fornara, Manuela $u National Research Council of Italy, Institute of Molecular Biology and Pathology
700    1_
$a Di Micco, Patrizio $u Department of Biochemical Sciences “A Rossi Fanelli”, University of Rome “Sapienza”
700    1_
$a Benada, Oldřich $7 xx0108253 $u Institute of Microbiology, Academy of Sciences of the Czech Republic, VVI, Prague, Czech Republic
700    1_
$a Křížan, Jiří $7 xx0098072 $u Institute of Microbiology, Academy of Sciences of the Czech Republic, VVI, Prague, Czech Republic
700    1_
$a Svoboda, Jan $7 xx0094349 $u Institute of Microbiology, Academy of Sciences of the Czech Republic, VVI, Prague, Czech Republic
700    1_
$a Hulíková, Katarína. $u Institute of Microbiology, Academy of Sciences of the Czech Republic, VVI, Prague, Czech Republic $7 _AN043256
700    1_
$a Morea, Veronica $u National Research Council of Italy, Institute of Molecular Biology and Pathology
700    1_
$a Boffi, Alberto $u Department of Biochemical Sciences “A Rossi Fanelli”, University of Rome “Sapienza”; Center for Life Nano Science at Sapienza, Italian Institute of Technology, Rome, Italy
700    1_
$a Ceci, Pierpaolo $u National Research Council of Italy, Institute of Molecular Biology and Pathology
773    0_
$w MED00176143 $t International journal of nanomedicine $x 1178-2013 $g Roč. 7(2012), s. 1489-1509
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22619508 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20121023 $b ABA008
991    __
$a 20200505133255 $b ABA008
999    __
$a ok $b bmc $g 956491 $s 791978
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 7 $d 1489-1509 $i 1178-2013 $m International journal of nanomedicine $n Int J Nanomedicine $x MED00176143
LZP    __
$b NLK112 $a Pubmed-20121023

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...